GATA2 Deficiency: Clinical Trials

2 trials for GATA2 Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow GATA2 Deficiency: new trials by email Literature Review of GATA2 Deficiency trials Research Report on GATA2 Deficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Total-Body Irradiation, Thiotepa, Fludarabine - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Active not recruitingFred Hutchinson Cancer Center452019-08-292026-09-25
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Azacitidine, Laboratory Biomarker Analysis, Lenalidomide - Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1
Phase 2Active not recruitingNational Cancer Institute (NCI)2822012-03-012026-09-09

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (1)  ·  Burkitt Lymphoma (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Mast-Cell (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Chronic Disease (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hematologic Neoplasms (1)

Interventions

Azacitidine (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Lenalidomide (1)  ·  Methotrexate (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)  ·  Vorinostat (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Marie Bleakley (1)  ·  Mikkael A Sekeres (1)

Results publications

PMID 29618479, PMID 33049057

NIH funding

P01CA018029 (1), P30CA015704 (1), U10CA032102 (1), U10CA180888 (1)